Arteris, Inc.
For the period ended Dec 31, 2025. Filed Feb 12, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 12, 2026
AIP$17.80+11.7%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(In thousands, except share and per share data)
| As of December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $33,901 | $13,684 |
| Short-term investments (Note 5) | 20,698 | 30,157 |
| Accounts receivable, net of allowance of $73 and $131 as of December 31, 2025, and 2024, respectively | 19,183 | 20,608 |
| Prepaid expenses and other current assets | 8,608 | 4,634 |
| Total current assets | 82,390 | 69,083 |
| Property and equipment, net | 3,872 | 4,019 |
| Long-term investments (Note 5) | 4,946 | 8,504 |
| Equity method investment | 2,989 | 5,802 |
| Operating lease right-of-use assets | 3,919 | 3,838 |
| Intangibles, net | 2,168 | 3,024 |
| Goodwill | 4,178 | 4,178 |
| Other assets | 10,569 | 7,687 |
| TOTAL ASSETS | $115,031 | $106,135 |
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||
| Current liabilities: | ||
| Accounts payable | $340 | $539 |
| Accrued expenses and other current liabilities | 19,094 | 15,899 |
| Operating lease liabilities, current | 1,233 | 917 |
| Deferred revenue, current | 51,367 | 40,445 |
| Vendor financing arrangements, current | 1,166 | 1,482 |
| Total current liabilities | 73,200 | 59,282 |
| Deferred revenue, noncurrent | 43,974 | 35,177 |
| Operating lease liabilities, noncurrent | 3,116 | 2,998 |
| Vendor financing arrangements, noncurrent | 452 | 594 |
| Deferred income, noncurrent | 6,452 | 7,631 |
| Other liabilities | 2,469 | 1,641 |
| Total liabilities | 129,663 | 107,323 |
| Commitments and contingencies (Note 11) | ||
| Stockholders’ deficit: | ||
| Preferred stock, par value of $0.001—10,000,000 shares authorized and no shares issued and outstanding as of both December 31, 2025, and 2024 | — | — |
| Common stock, par value of $0.001—300,000,000 shares authorized at December 31, 2025, and 2024; 44,268,816 and 40,724,936 shares issued and outstanding at December 31, 2025, and 2024, respectively | 44 | 40 |
| Additional paid-in capital | 156,776 | 135,522 |
| Accumulated other comprehensive income | 179 | 135 |
| Accumulated deficit | (171,631) | (136,885) |
| Total stockholders’ deficit | (14,632) | (1,188) |
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT | $115,031 | $106,135 |
See notes to consolidated financial statements
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.